Key statistics
On Friday, Evolus Inc (EOLS:NMQ) closed at 13.68, -23.23% below its 52-week high of 17.82, set on Oct 14, 2024.
52-week range
Short selling activityProvided by S&P Global Market Intelligence
Open | 14.28 |
---|---|
High | 14.35 |
Low | 13.35 |
Bid | 10.65 |
Offer | 17.00 |
Previous close | 14.29 |
Average volume | 677.19k |
---|---|
Shares outstanding | 63.32m |
Free float | 49.78m |
P/E (TTM) | -- |
Market cap | 866.24m USD |
EPS (TTM) | -0.9141 USD |
Data delayed at least 15 minutes, as of Nov 08 2024 21:00 GMT.
More ▼
- Evolus Reports Third Quarter 2024 Results
- Evolus to Participate in Stifel 2024 Healthcare Conference
- Evolus Announces EU Approval of Estyme® Injectable Hyaluronic Acid Gels Under New Medical Device Regulation
- Evolus Rewards™ Patient Loyalty Program Surpasses 1 Million Enrolled Consumers
- Evolus to Report Third Quarter Financial Results on November 6, 2024
- Evolus Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
- Evolus to Ring the Nasdaq Stock Market Closing Bell on Friday, September 13, 2024
More ▼